Cite
Abstract P3124: Treatment Of Apoe -/- Mice With Advanced Atherosclerosis With The Senolytic Agent Abt-263 Caused Increased Mortality And Was Associated With Increased Endo-mt But Reduced Acta2 Cap Thickness And Collagen Content
MLA
Santosh Karnewar, et al. “Abstract P3124: Treatment Of Apoe -/- Mice With Advanced Atherosclerosis With The Senolytic Agent Abt-263 Caused Increased Mortality And Was Associated With Increased Endo-Mt But Reduced Acta2 Cap Thickness And Collagen Content.” Circulation Research, vol. 131, Aug. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........e713ec4f3c4affc5559acad4cdb5206c&authtype=sso&custid=ns315887.
APA
Santosh Karnewar, Vaishnavi Karnewar, & Gary K Owens. (2022). Abstract P3124: Treatment Of Apoe -/- Mice With Advanced Atherosclerosis With The Senolytic Agent Abt-263 Caused Increased Mortality And Was Associated With Increased Endo-mt But Reduced Acta2 Cap Thickness And Collagen Content. Circulation Research, 131.
Chicago
Santosh Karnewar, Vaishnavi Karnewar, and Gary K Owens. 2022. “Abstract P3124: Treatment Of Apoe -/- Mice With Advanced Atherosclerosis With The Senolytic Agent Abt-263 Caused Increased Mortality And Was Associated With Increased Endo-Mt But Reduced Acta2 Cap Thickness And Collagen Content.” Circulation Research 131 (August). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........e713ec4f3c4affc5559acad4cdb5206c&authtype=sso&custid=ns315887.